University of California, Los Angeles (UCLA), Health Sciences

Patients of women doctors more likely to be vaccinated against the flu

Findings could have implications for boosting COVID-19 vaccination rates

Newswise — New UCLA research suggests that elderly patients of female physicians are more likely than those of male physicians in the same outpatient practice to be vaccinated against the flu. 

This trend holds for all racial and ethnic groups studied and could provide insight into improving vaccination rates for influenza, COVID-19 and other illnesses, according to the research letter, which is published in the peer-reviewed JAMA Internal Medicine. 

Prior studies have shown that female physicians tend to spend more time with their patients, said study author Dr. Dan Ly, an assistant professor in the division of general internal medicine and health services research at the David Geffen School of Medicine at UCLA

“Now we’re trying to vaccinate against COVID-19, and we will soon get to a point where most adults who want a vaccine will get it,” Ly said. “We’ll then need to reach those who need more convincing in order to be vaccinated, and my research suggests that perhaps this extra time spent may be helpful in getting these patients vaccinated. 

“In general, flu vaccines are 40% to 60% effective. But COVID-19 vaccines are more than 90% effective, and even more so against severe disease,” he said. “This means that the time spent to convince a patient to get vaccinated against COVID-19 is time well spent, not to mention the societal benefits coming from it.” 

People in some racial and ethnic groups, particularly Black people, are less likely to be vaccinated for a variety of complex reasons. 

Ly examined Medicare claims data from 2006 through 2016 for both male and female beneficiaries age 65 years and older from four racial and ethnic groups: white, Black, Asian and Hispanic. The research sample about included approximately 40 million patient visits to about 150,000 female physicians and 300,000 male physicians. 

Ly found that patients of female physicians were vaccinated at higher rates than those of male physicians across the board: 

  • Among white men, the vaccination rate was 52.7% for those seen by female physicians, compared with 52.0% for male physicians. For white women, the rates were 54.6% (female physician) and 53.8% (male physician).
  • Rates for Black men were 39.8% vs. 38.1%; for Black women, 41.6% vs. 40.3%.
  • Among Asian men, rates were 56.8% vs. 54.7%; for Asian women, 56.4% vs. 55.7%.
  • For Hispanic man, rates were 48.9% vs. 47.3%; for Hispanic women, 50.6% vs. 49.1%.

 Ly also found that female physicians were more likely than male physicians to get patients with more chronic conditions and co-mordibities vaccinated.

 Overall, Black patients were about 14 percentage points less likely, and Hispanics 5 percentage points less likely, than whites to be vaccinated. Differences in vaccination rates between patients of female and male physicians, Ly found, represented 10% of the white–Black gap and about 30% of the white–Hispanic gap. 

Differences in communication style between female and male physicians, which have been documented in previous studies, may also contribute to the differences vaccination rates, Ly noted.

SEE ORIGINAL STUDY



Filters close

Showing results

110 of 5872
Released: 24-Jun-2021 4:55 PM EDT
Virus that causes COVID-19 can find alternate route to infect cells
Washington University in St. Louis

The virus that causes COVID-19 normally gets inside cells by attaching to a protein called ACE2. Researchers at Washington University School of Medicine in St. Louis have found that a single mutation confers the ability to enter cells through another route, which may threaten the effectiveness of COVID-19 vaccines and therapeutics designed to block the standard route of entry.

Newswise: Is it a Virus or Bacteria? New Tech Rapidly Tests for COVID-19 and More
Released: 24-Jun-2021 3:05 PM EDT
Is it a Virus or Bacteria? New Tech Rapidly Tests for COVID-19 and More
Homeland Security's Science And Technology Directorate

S&T is preparing for future outbreaks/pandemics by investing in a new tech that can quickly discriminate between bacterial and viral infections so that the U.S. can triage patients and plan a response without delay.

Released: 24-Jun-2021 12:30 PM EDT
A tecnologia de IA e ECG pode descartar rapidamente a infecção por COVID-19, concluiu o estudo da Mayo Clinic
Mayo Clinic

A inteligência artificial (IA) pode oferecer uma maneira de determinar com precisão se uma pessoa não está infectada com a COVID-19. Um estudo retrospectivo internacional descobriu que a infecção pelo SARS-CoV-2, o vírus que causa a COVID-19, cria mudanças elétricas sutis no coração. Um eletrocardiograma (ECG) habilitado com IA pode detectar essas alterações e, potencialmente, ser usado como um teste de triagem rápido e confiável para descartar a infecção por COVID-19.

Released: 24-Jun-2021 12:10 PM EDT
妙佑医疗国际(Mayo Clinic)的研究发现,AI赋能的心电图技术有可能迅速排除COVID-19感染
Mayo Clinic

AI (人工智能)有可能提供准确判断一个人未感染COVID-19(2019冠状病毒病)的方法。一项国际回顾性研究发现,如果感染了导致COVID-19的SARS-CoV-2病毒,患者的心脏会产生微妙的电学变化。AI赋能的心电图(EKG)可以检测到这些变化,并有望被用于进行快速、可靠的COVID-19筛查检测,以排除COVID-19感染。

Newswise: 200421_Felgner_3205_sz-2-768x496.jpg
Released: 24-Jun-2021 11:50 AM EDT
UCI Professor Wins Spain’s Prestigious Princess of Asturias Award for Scientific Research
University of California, Irvine

Irvine, Calif., June 24, 2021 — Philip Felgner, Ph.D., professor in residence of physiology & biophysics at the University of California, Irvine, is one of seven scholars worldwide to win Spain’s prestigious Princess of Asturias Award for Technical and Scientific Research in recognition of their contributions to designing COVID-19 vaccines.

Released: 24-Jun-2021 11:00 AM EDT
New protein engineering method could accelerate the discovery of COVID-19 therapeutics
University of Michigan

Discovering and engineering nanobodies with properties suitable for treating human diseases ranging from cancer to COVID-19 is a time-consuming, laborious process.

Newswise: Decoding humans’ survival from coronaviruses
Released: 24-Jun-2021 11:00 AM EDT
Decoding humans’ survival from coronaviruses
University of Adelaide

An international team of researchers co-led by the University of Adelaide and the University of Arizona has analysed the genomes of more than 2,500 modern humans from 26 worldwide populations, to better understand how humans have adapted to historical coronavirus outbreaks.

access_time Embargo lifts in 2 days
Embargo will expire: 29-Jun-2021 4:00 PM EDT Released to reporters: 24-Jun-2021 10:35 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 29-Jun-2021 4:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: COVIDLockdownSimulations.jpg
Released: 24-Jun-2021 10:00 AM EDT
Pandemic Air Quality Affected By Weather, Not Just Lockdowns
Washington University in St. Louis

Using a diverse set of tools, the lab of Randall Martin shows how the pandemic did – or didn’t – affect levels of particulate matter during COVID lockdowns.

Released: 24-Jun-2021 6:05 AM EDT
Longest known SARS-CoV-2 infection of nearly 300 days successfully treated with new therapy
University of Bristol

An immunocompromised individual with the longest known PCR confirmed case of SARS-CoV-2 infection, lasting more than 290 days, has been successfully treated with two investigational monoclonal antibodies (laboratory engineered antibodies). Clinicians and researchers from the University of Bristol and North Bristol NHS Trust (NBT) worked closely to assess and treat the infection and want to highlight the urgent need for improved access to treatments for such people with persistent SARS-CoV-2 infection.


Showing results

110 of 5872

close
1.15353